These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1661516)

  • 21. Population incidence and segregation ratios in the Martin-Bell syndrome.
    Webb TP; Bundey SE; Thake AI; Todd J
    Am J Med Genet; 1986; 23(1-2):573-80. PubMed ID: 3953667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mental impairment in cytogenetically positive fragile X females.
    Cronister A; Hagerman RJ; Wittenberger M; Amiri K
    Am J Med Genet; 1991; 38(2-3):503-4. PubMed ID: 2018094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Martin-Bell syndrome in South Africa.
    Venter PA; Op't Hof J; Coetzee DJ
    Am J Med Genet; 1986; 23(1-2):597-610. PubMed ID: 3953670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mental retardation in heterozygotes for the fragile-X mutation: evidence in favor of an X inactivation-dependent effect.
    Rocchi M; Archidiacono N; Rinaldi A; Filippi G; Bartolucci G; Fancello GS; Siniscalco M
    Am J Hum Genet; 1990 Apr; 46(4):738-43. PubMed ID: 2316520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragile X syndrome with extra microchromosome.
    López-Pajares I; Delicado A; Pascual-Castroviejo I; López-Martin V; Moreno F; Garcia-Marcos JA
    Clin Genet; 1994 Apr; 45(4):186-9. PubMed ID: 8062436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The comparison of anthropometric variables in mentally retarded boys with and without fragile X syndrome.
    Lisik M; Szymańska-Parkieta K; Gałecka U
    Clin Genet; 2000 Jun; 57(6):456-8. PubMed ID: 10905668
    [No Abstract]   [Full Text] [Related]  

  • 27. Fragile X expression in normal and mentally retarded subjects: effect of treatment with an antifolic agent.
    Sanfilippo S; Ragusa RM; Scillato F; Ruggeri M; Neri G
    Am J Med Genet; 1988; 30(1-2):369-76. PubMed ID: 3177459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fragile Xq27.3 in female heterozygotes for the Martin-Bell syndrome.
    Webb T; Jacobs PA
    J Med Genet; 1990 Oct; 27(10):627-31. PubMed ID: 2246771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moderate and mild mental retardation in the Martin-Bell syndrome.
    Webb T; Thake A
    J Ment Defic Res; 1991 Dec; 35 ( Pt 6)():521-8. PubMed ID: 1800751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical, cytogenetic and familial study of 307 mentally retarded, institutionalized, adult male patients with special interest for fra(X) negative X-linked mental retardation.
    Haspeslagh M; Fryns JP; Holvoet M; Collen G; Dierck G; Baeke J; van den Berghe H
    Clin Genet; 1991 Jun; 39(6):434-41. PubMed ID: 1863991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The fragile X in Sicily: an epidemiological survey.
    Neri G; Sanfilippo S; Pavone L; Mollica F; Barberi I; Giuffrè L; Romano C; Mattina T; Cammarata M; Ragusa MG
    Am J Med Genet; 1988; 30(1-2):665-72. PubMed ID: 3177477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Martin-Bell syndrome segregating in a large kindred with normal transmitting males: clinical, cytogenetic, and linkage study.
    Johnson VP; Carpenter NJ; Skorey PA
    Am J Med Genet; 1991; 38(2-3):275-82. PubMed ID: 1673299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two families with Xq27.3 fragility, no detectable insert in the FMR-1 gene, mild mental impairment, and absence of the Martin-Bell phenotype.
    Dennis NR; Curtis G; Macpherson JN; Jacobs PA
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):232-6. PubMed ID: 1605196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A community study of severe mental retardation in the West Midlands and the importance of the fragile X chromosome in its aetiology.
    Bundey S; Webb TP; Thake A; Todd J
    J Med Genet; 1985 Aug; 22(4):258-66. PubMed ID: 4045951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the segregation of the fragile X mutation in daughters of obligate carrier women.
    Sherman SL; Turner G; Robinson H; Laing S
    Am J Med Genet; 1988; 30(1-2):633-9. PubMed ID: 3177475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinico-electrophysiological examination of children with Martin-Bell syndrome].
    Lastochkina NA; Kuprianova TA; Puchinskaia LM; Marincheva GS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(3):69-75. PubMed ID: 2163175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening developmentally disabled male populations for fragile X: the effect of sample size.
    Fisch GS; Cohen IL; Jenkins EC; Brown WT
    Am J Med Genet; 1988; 30(1-2):655-63. PubMed ID: 3052070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Possibility of EEG-diagnosis of heterozygotic Martin-Bell syndrome].
    Moskovkina AG; Blagosklonova NK
    Genetika; 1990 Oct; 26(10):1865-9. PubMed ID: 2283054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 'fragile' X chromosome in the Martin-Bell-Renpenning syndrome and in males with other forms of familial mental retardation.
    Proops R; Webb T
    J Med Genet; 1981 Oct; 18(5):366-73. PubMed ID: 7328617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical, cytogenetic and molecular aspects of fragile X syndrome].
    Veenema H
    Tijdschr Kindergeneeskd; 1989 Oct; 57(5):153-8. PubMed ID: 2683200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.